BGI and Diagenode To Co-Develop Standardization Methods for Epigenetics Sample-Prep for NGS | GenomeWeb

BGI and Diagenode will collaborate to develop standard methods in sample prep for next-generation sequencing for epigenetics research, the companies said today.

Under the deal, Diagenode will provide BGI with early access to its developments in chromatin- and DNA methylation-analysis methods and tools. The company is aiming to "increase the consistency and precision" of its epigenetic sample-prep assays for next-gen sequencing, including its ChIP, MeDIP, methyl-CpG biding domain protein capture, bisulfite conversion, and DNA fragmentation assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.